A phase 2 randomized, double-blinded, controlled study of ONT-380 vs. placebo in combination with capecitabine (C) and trastuzumab (T) in patients with pretreated HER2+unresectable locally advanced or metastatic breast carcinoma (MBC)
| Affiliation auteurs | Affiliation ok |
| Titre | A phase 2 randomized, double-blinded, controlled study of ONT-380 vs. placebo in combination with capecitabine (C) and trastuzumab (T) in patients with pretreated HER2+unresectable locally advanced or metastatic breast carcinoma (MBC) |
| Type de publication | Journal Article |
| Year of Publication | 2016 |
| Auteurs | Curigliano G., Loibl S., Mueller V., Pivot X., Wardley A., Cameron D. |
| Journal | ANNALS OF ONCOLOGY |
| Volume | 27 |
| Date Published | OCT 1 |
| Type of Article | Meeting Abstract |
| ISSN | 0923-7534 |
| DOI | 10.1093/annonc/mdw365.91 |